Evidence that neurotensin mediates the central effect of leptin on food intake in rat.
Recent evidence suggests that leptin's action on food intake and body weight regulation is mediated by a number of orexigenic and anorectic neuronal systems in the hypothalamus. Our previous demonstration that central injections of leptin induce hypothalamic neurotensin (NT) gene expression in association with a reduced food intake and decreased body weight in rats indicates that NT, an anorectic peptide, is involved in mediating leptin's action on feeding and body weight regulation. To begin to examine the relative role of NT in this regard we evaluated the effects of NT antiserum (NT-AS) or NT receptor antagonist, SR 48692, on the satiety action of leptin in rats. In the first experiment, 3rd cerebroventricular (i.c.v.) administration of either 1 or 5 microl of NT-AS, 30 min prior to leptin (4 microg) injection, completely blocked the effects of leptin on food deprivation (FD)-induced feeding. In the second experiment, intraperitoneal (i.p.) administration of SR 48692 (40 microg/kg) also completely prevented leptin's satiety action on FD-induced feeding. These results showing the reversal of leptin's satiety action by either NT immunoneutralization or NT-receptor antagonism support our hypothesis that NT is involved in mediating leptin's action on feeding and further suggest that this neuropeptide is a quantitatively important component of the leptin sensitive neural circuitry.
Sahu
A
A
Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, S-829 Scaife Hall, 3550 Terrace Street Pittsburgh, PA 15261, USA. asahu@pitt.edu
Carraway
R E
RE
Wang
Y P
YP
D000818:Animals; D001069:Appetite Regulation / Q000187:drug effects / Q000502:physiology*; D005508:Food Deprivation / Q000502:physiology; D007106:Immune Sera / Q000008:administration & dosage; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D020738:Leptin / Q000008:administration & dosage / Q000378:metabolism*; D008297:Male; D009496:Neurotensin / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D011720:Pyrazoles / Q000008:administration & dosage; D011804:Quinolines / Q000008:administration & dosage; D051381:Rats; D017207:Rats, Sprague-Dawley; D018028:Receptors, Neurotensin / Q000037:antagonists & inhibitors; D012528:Satiety Response / Q000187:drug effects
D007106:Immune Sera; D020738:Leptin; D011720:Pyrazoles; D011804:Quinolines; D018028:Receptors, Neurotensin; C079087:SR 48692; D009496:Neurotensin